1Siegel R, Naishadham D. Cancer statistics[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
2Sokal JE. Incidence of malignancy in toxic and non-toxic nodular goiter[J].JAMA, 1954, 154: 1321-1325.
3Gabrelea R, Letiziab C, Bozghesea M, et al.yzoid cancer in patients with hyperthyroidism[J]. Hormone Res, 2003, 60: 79-83.
4Cirid J, Beleslin-Nedeljkovid B. Differentiated thyroid carcinoma in previously manifested autoimmune thyroid disease[J]. Srp Arh Celok Lek, 2005, 133(1): 74-6.
5Kraimps JL, Bovin-Pinean MH, Mathonnet M, et al. Multicentric study of thyroid nodules in patients with Graves' disease[J]. BrJ Surg, 2000, 87:1111-1113.
6Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism[J]. Hormo Metabo Res, 2012, 44(4): 255-262.
7Shu X, Ji J, Li X, et al. Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden[J]. BrJ Cancer, 2010, 102: 1397-1399.
8Chen YK, Lin CL, Chang YJ, et al. Cancer Risk in Patients with Graves' Disease:A Nationwide Cohort Study[J]. Tayroid, 2013, 23(7).
9Belfiore A, Garofalot M, Giuffrida D, et al. Increased Aggressiveness of Thyroid Cancer in Patients with Graves' Disease[J], J Clin Endocrinol Metab, 1990, 70(4): 830-835.
10Pellegriti G, Belfiore A, Ginffrida D, et al. Outcome of Differentiated Thyroid Cancer in Graves' Patients [J]. J Clin Er;docrinol Metab, 1998, 83(8): 2805-2809.
